Overall burden to society caused by hyperkinetic syndrome (HKS) and attention deficit hyperactivity disorder (ADHD);Die gesamtgesellschaftliche belastung durch die hyperkinetische störung (HKS) bzw. aufmerksamkeitsdefizit-/hyperaktivitätsstörung (ADHS)

Gesundheitswesen

Volumn 70, Issue 7, 2008, Pages 398-403

  Schoffski O ^a   Sohn, S ^a   Happich, M ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

ADHD; Cost of illness; Costs; HKS

Indexed keywords

ARTICLE; ATTENTION DEFICIT DISORDER; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HUMAN; HYPERKINESIA; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COST OF ILLNESS; GERMANY; HEALTH CARE COSTS; HUMANS;

EID: 51849127791     PISSN: 09413790     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1082049     Document Type: Article

References (40)

1. Brecht J, Jenke A, Köhler M et al. Empfehlungen der Deutschen Gesellschaft für klinische Pharmakologie und Therapie zur Durchführung und Bewertung pharmakoökonomischer Studien. Med Klin 1995; 90: 541-546
2. Schöffski O, Uber A. Grundformen gesundheitsökonomischer Evaluationen. In: Schöffski O, Graf vd, Schulenburg JH, eds. Gesundheitsökonomische Evaluationen. Berlin, Heidelberg u.a.: Springer 2000; 175-203
3. Rowland A, Lesesne C, Abramowitz A. The epidemiology of attention-deficit/hyperactivity disorder(ADHD): A public health view. Mental Retardation and Developmental Disabilities Research Reviews 2002; 8: 162-170
4. Goldmann J, Genel M, Bezmann R. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA 1998; 14: 1100-1107
5. Barbaresi W, Katusic S, Colligan R et al. How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: results from a population-based study. Acta Paediatr Suppl 2004; 445: 55-59
6. Huss M. Vorbereitung der Erhebung und Auswertung zur Prävalenz des Aufmerksamkeits-Defizit-Hyperaktivitäts-Syndroms (ADHS) in Deutschland im Rahmen des Kinder- und Jugendsurveys des Robert-Koch- Instituts. Abschlussbericht an das Bundesministerium für Gesundheit und soziale Sicherung (BMGS) 2004
7. Bundesärztekammer Stellungnahme zur "Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung (ADHS)". Dtsch Arztebl 2005; 102: 51-52
8. Biederman J. Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2004; 65: 3-7
9. Kordon A, Kahl KG. Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung im Erwachsenenalter. Psychter Psych Med 2004; 54: 124-136
10. Statistisches Bundesamt. Sonderauswertung zur Krankheitskostenrechnung 2002 für Lilly Deutschland GmbH zu ICD-10 F90, 2004
11. Glaeske G, Janhsen K, Schicktanz C, Scharnetzky E. Arzneimittel-Versorgung von Kindern mit hyperkinetischen Störungen 2002
12. Schwabe U, Paffrath D. Arzneiverordnungs-Report 2003. Berlin, Heidelberg: Springer 2003
13. Schubert I, Köster I, Adam Chr IP, Ferber Lv LG. Hyperkinetische Störung als Krankenscheindiagnose bei Kindern und Jugendlichen. Eine versorgungsepidemiologische Studie auf der Basis der Versichertenstichprobe KV Hessen/AOK Hessen Abschlussbericht für Bundesministerium für Gesundheit und Soziale Sicherung. Veröffentlichung durch BMGS im Druck 2002
14. Leibson CL, Long KH. Economic Implications of Attention-Deficit Hyperactivity Disorder for Healthcare Systems. PharmacoEconomics 2003; 21: 1239-1262
15. Matza LS, Paramore C, Prasad M. A review of the economic burden of ADHD. Cost effectiveness and resource allocation: C/E 2005; 3: 5
16. Marchetti A, Magar R, Lau H et al. Pharmacotherapies for attention-deficit/hyperactivity disorder: Expected-cost analysis. Clinical Therapeutics: The International Peer-Reviewed Journal of Drug Therapy 2001; 23: 1904-1921
17. Chan E, Zhan C, Homer CJ. Health care use and costs for children with attention-deficit/hyperactivity disorder national estimates from the medical expenditure panel survey. Arch Pediat Adol Med 2002; 156: 504-511
18. Guevara J, Lozano P, Wickizer T, Mell L, Gephart H. Utilization and cost of health care services for children with attention-deficit/ hyperactivity disorder. Pediatrics 2001; 108: 71-78
19. Swensen AR, Birnbaum HG, Ben Hamadi R et al. Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients. J Adol Health 2004; 35: 346-346
20. DiScala C, Lescohier I. Injuries to children with attention deficit hyper-activity disorder. Pediatrics 1998; 102: 1425-1421
21. Barkley RA, Murphy KR. Motor vehicle driving competencies and risks in teens and young adults with attention deficit. Pediatrics 1996; 98: 1089-1095
22. Gayton WF, Bailey C, Wagner A, Hardesty VA. Relationship between childhood hyperactivity and accident proneness. Percept Motor Skill 1986; 63: 801-802
23. Murphy K, Barkley RA. Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments. Compr Psychiat 1996; 37: 393-401
24. Burd L, Klug MG, Coumbe MJ, Kerbeshian J. The attention-deficit hyperactivity disorder paradox: 2. phenotypic variability in prevalence and cost of comorbidity. J Child Neurol 2003; 18: 653-660
25. Pliszka SR. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Child Adol Psych Cl 2000; 9: 525-540
26. Secnik K, Swensen A, Lage MJ. Comorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder. Pharmaco-Economics 2005; 23: 93-102
27. Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: antisocial activities and drug use. J Child Psychol Psych 2004; 45: 195-211
28. Hansen C, Weiss D, Last CG. ADHD boys in young adulthood: Psychosocial adjustment. J Am Acad Child Psy 1999; 38: 165-171
29. Mannuzza S, Klein RG, Konig PH, Giampino TL. Hyperactive boys almost grown up: IV. Criminality and its relationship to psychiatric status. Arch Gen Psychiat 1991; 48: 1073-1079
30. Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil 1998; 31: 533-544
31. Kollins SH, MacClernon FJ, Fuemmeler BF. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiat 2005; 62: 1142-1147
32. Pomerleau OF, Downey KK, Stetson FW, Pomerleau CS. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 1995; 7: 373-378
33. Hechtman L, Weiss G, Perlman T. Hyperactives as young adults: Past and current substance abuse and antisocial behavior. Am J Orthopsychiat 1984; 54: 415-425
34. Millberger S, Biederman J, Faraone S, Wilens T, Chu MP. Associations between ADHD and psychoactive substance use disorders. Am J Addict 1997; 6: 318-329
35. Mannuzza S, Klein RG, Bessler A, Malloy P. Adult outcome of hyperactive boys: Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiat 1993; 50: 565-576
36. Barkley RA, Fischer M, Smallish L, Fletcher K. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics 2003; 111: 97-109
37. Birnbaum HG, Kessler RC, Lowe SW et al. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin 2005; 21: 195-206
38. Kessler RC, Adler L, Ames M et al. The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med 2005; 47: 565-572
39. Mannuzza S, Klein RG. Long-term prognosis in attention-deficit/ hyperactivity disorder. Child Adol Psych Cl 2000; 9: 711-726
40. Swensen AR, Birnbaum HG, Secnik K et al. Attention-deficit/ hyperactivity disorder: Increased costs for patients and their families. Am Acad Child Psy 2003; 42: 1415-1423